• Please log in or register to access this feature.

Research Article

Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial

  1. Marjolein A. van der Marck MSc1,
  2. Bastiaan R. Bloem MD, PhD2,
  3. George F. Borm PhD3,
  4. Sebastiaan Overeem MD, PhD2,
  5. Marten Munneke PhD1,4,
  6. Mark Guttman MD, FRCPC5,*

Article first published online: 19 NOV 2012

DOI: 10.1002/mds.25194

Issue

Movement Disorders

Movement Disorders

Volume 28, Issue 5, pages 605–611, May 2013

Additional Information

How to Cite

van der Marck, M. A., Bloem, B. R., Borm, G. F., Overeem, S., Munneke, M. and Guttman, M. (2013), Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial. Mov. Disord., 28: 605–611. doi: 10.1002/mds.25194

Author Information

  1. 1

    Radboud University Nijmegen Medical Centre, Nijmegen Centre for Evidence Based Practice, Department of Neurology, Nijmegen, The Netherlands

  2. 2

    Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Nijmegen, The Netherlands

  3. 3

    Radboud University Nijmegen Medical Centre, Department of Epidemiology, Biostatistics and HTA, Nijmegen, The Netherlands

  4. 4

    Radboud University Nijmegen Medical Centre, Nijmegen Centre for Evidence Based Practice, Scientific Institute for Quality of Healthcare, Nijmegen, The Netherlands

  5. 5

    University of Toronto, Division of Neurology, Department of Medicine, Toronto, Ontario, Canada

*Correspondence to: Dr. Mark Guttman, Division of Neurology, Department of Medicine, University of Toronto, 2780 Bur Oak Avenue, Markham, Ontario L6B 1C9, Canada; mguttman@movementdisorders.ca

  1. Funding agencies: This study was financially supported by funding from the Ministry of Health and Long-Term Care of the Province of Ontario, Canada, and the National Parkinson Foundation (NPF). The funding sources had no role in the design, data collection, analysis, interpretation of data, writing of the report or the decision to submit the article. M.A.v.d.M. is sponsored by the NutsOhra Foundation, Stichting Porticus, and the National Parkinson Foundation. S.O. was supported by a VIDI research grant (grant no.: 016.116.371) from the Netherlands Organisation for Scientific Research.

  2. Relevant conflicts of interest/financial disclosures: Nothing to report.

  3. Full financial disclosures and author roles may be found in the online version of this article.

Publication History

  1. Issue published online: 15 MAY 2013
  2. Article first published online: 19 NOV 2012
  3. Manuscript Accepted: 20 AUG 2012
  4. Manuscript Revised: 6 AUG 2012
  5. Manuscript Received: 3 MAR 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (347K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (347K)